Published in Neoplasia on September 01, 2000
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev (2001) 5.67
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev (2009) 2.52
A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res (2009) 2.30
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia (2006) 2.30
Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia (2005) 2.17
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res (2010) 1.81
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia (2005) 1.45
Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia (2002) 1.32
Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol (2011) 1.22
Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma. Neuro Oncol (2011) 1.16
Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice. Neoplasia (2007) 1.08
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine. Mol Cancer Ther (2008) 1.08
MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia (2002) 1.08
DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol (2011) 1.07
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.06
Water spin dynamics during apoptotic cell death in glioma gene therapy probed by T1rho and T2rho. Magn Reson Med (2008) 1.05
Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy. IEEE J Sel Top Quantum Electron (2011) 1.05
The biology underlying molecular imaging in oncology: from genome to anatome and back again. Clin Radiol (2010) 1.04
Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol (2009) 1.04
MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer. NMR Biomed (2011) 1.03
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia (2004) 1.03
Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study. Br J Cancer (2009) 0.95
Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. Neoplasia (2005) 0.93
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Mol Imaging (2011) 0.92
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells. PLoS One (2013) 0.91
Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. Neoplasia (2005) 0.90
Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model. Magn Reson Imaging (2012) 0.89
Imaging biochemistry: applications to breast cancer. Breast Cancer Res (2000) 0.88
Enhancement of histological volumes through averaging and their use for the analysis of magnetic resonance images. Magn Reson Imaging (2008) 0.86
The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods. MAGMA (2004) 0.85
DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases. Transl Oncol (2013) 0.83
Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2. Neoplasia (2002) 0.82
Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy. BMC Res Notes (2012) 0.79
Use of the 1-mm micro-probe for metabolic analysis on small volume biological samples. J Cell Mol Med (2009) 0.78
Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation. J Magn Reson Imaging (2015) 0.76
Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model. Med Phys (2015) 0.75
Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy. Biomed Opt Express (2016) 0.75
On the origin of cancer cells. Science (1956) 49.55
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology (1986) 11.58
The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer (1955) 10.49
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology (1999) 6.50
Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res (1989) 5.62
Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med (1998) 3.85
The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol (1984) 3.44
Apoptosis induced by anticancer drugs. Cancer Metastasis Rev (1992) 3.07
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res (1986) 2.98
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (1997) 2.96
Time-dependent diffusion of water in a biological model system. Proc Natl Acad Sci U S A (1994) 2.59
Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol (1998) 2.36
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia (1999) 2.24
Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer (1996) 2.20
Imaging transgene expression with radionuclide imaging technologies. Neoplasia (2000) 2.03
31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol (1994) 2.00
The measurement of oxygen in vivo using EPR techniques. Phys Med Biol (1998) 1.97
Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer (1999) 1.79
Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther (1998) 1.62
Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1995) 1.62
Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology (1997) 1.62
Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res (1990) 1.59
Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum Gene Ther (1998) 1.51
pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol (1999) 1.48
Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev (1987) 1.48
Restricted diffusion in biophysical systems. Experiment. Biophys J (1974) 1.44
In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol (1995) 1.44
Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusion-weighted echo-planar MR imaging. J Magn Reson Imaging (1999) 1.41
MR imaging and scintigraphy of gene expression through melanin induction. Radiology (1997) 1.38
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med (1999) 1.38
Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol (1999) 1.38
Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res (1998) 1.33
Hypoxia and Radiation Response in Human Tumors. Semin Radiat Oncol (1996) 1.33
Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet (1997) 1.31
Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta (1998) 1.31
Simultaneous multi-site EPR spectroscopy in vivo. Magn Reson Med (1993) 1.28
Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood (1996) 1.28
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1999) 1.26
Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (2000) 1.25
Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys (1998) 1.20
Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther (1998) 1.19
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res (1988) 1.18
Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR. Magn Reson Med (1997) 1.17
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res (1998) 1.17
Monitoring of cell volume and water exchange time in perfused cells by diffusion-weighted 1H NMR spectroscopy. NMR Biomed (1998) 1.14
Diffusion imaging of human breast. NMR Biomed (1997) 1.13
Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med (1998) 1.12
Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy. Cancer Res (1992) 1.09
Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J Biol Chem (1999) 1.09
Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation. NMR Biomed (1996) 1.07
Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology (1996) 1.07
Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Br J Cancer (1998) 1.05
The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity. Cancer Res (1991) 1.01
Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. Br J Cancer Suppl (1996) 1.00
Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry. Radiat Res (1998) 0.98
Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology (1997) 0.98
The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys (1997) 0.97
A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn Reson Med (1993) 0.94
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer (1999) 0.94
Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase. Hum Gene Ther (1999) 0.94
The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer (1995) 0.94
Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res (1988) 0.94
Induction of apoptosis in two mammalian cell lines results in increased levels of fructose-1,6-bisphosphate and CDP-choline as determined by 31P MRS. Magn Reson Med (1998) 0.94
Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro. Cancer Res (1997) 0.93
Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Cancer Res (1995) 0.93
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin. Clin Cancer Res (1998) 0.93
Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. J Neurooncol (1998) 0.92
Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol (1998) 0.91
Weak acids, weak bases and intracellular pH. Respir Physiol (1978) 0.90
Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate. Cancer Res (1979) 0.89
Effective nutritional ergogenic aids. Int J Sport Nutr (1999) 0.88
Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. Br J Cancer (1997) 0.87
Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed (1994) 0.86
Vascular and extravascular spaces in a transplantable rat tumour after local X-ray irradiation. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.86
Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging. Radiology (1998) 0.86
TNF-induced modulations of phospholipid metabolism in human breast cancer cells. Biochim Biophys Acta (1998) 0.85
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI. Int J Radiat Oncol Biol Phys (1998) 0.85
Characterisation of secondary metabolites associated with neutrophil apoptosis. FEBS Lett (1996) 0.84
Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Clin Cancer Res (1995) 0.83
31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J Cell Physiol (1994) 0.83
Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther (1995) 0.83
Chemotherapeutic evaluation using clinical criteria in spontaneous, autochthonous murine breast tumors. J Natl Cancer Inst (1988) 0.82
Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Magn Reson Med (1996) 0.82
Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol (1994) 0.82
Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action. NCI Monogr (1988) 0.82
31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res (1989) 0.82
Blood oxygenation. Heterogeneity of hypoxic tissues monitored using bold MR imaging. Adv Exp Med Biol (1997) 0.82
Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study. Cancer Res (1989) 0.81
Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther (1995) 0.80
Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model. Radiat Res (1999) 0.80
Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging (1999) 0.80
MR imaging of blood oxygenation-dependent changes in focal renal ischemia and transplanted liver tumor in rat. J Magn Reson Imaging (1993) 0.79
31P and 13C NMR spectroscopic study of wild type and multidrug resistant Ehrlich ascites tumor cells. Oncol Res (1993) 0.79
Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. Cancer Res (1982) 0.79
13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro. J Biol Chem (1996) 0.78
The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study. Biochem Biophys Res Commun (1989) 0.78
Nitrogen mustard up-regulates Bcl-2 and GSH and increases NTP and PCr in HT-29 colon cancer cells. Br J Cancer (1998) 0.78
Potentiation of a three drug chemotherapy regimen by radiation. Cancer Res (1993) 0.77
Quality assessment in health. Br Med J (Clin Res Ed) (1984) 8.78
Gluconeogenesis in the perfused rat liver. Biochem J (1966) 8.58
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99
The Osteopaths Bill. BMJ (1993) 3.16
Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N Engl J Med (1981) 3.00
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia (2001) 2.97
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (1997) 2.96
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology (1991) 2.77
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med (1993) 2.59
Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc Natl Acad Sci U S A (1993) 2.50
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A (2000) 2.49
Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis (1996) 2.44
Determination of cell number in monolayer cultures. Anal Biochem (1986) 2.43
Metabolic activities of the isolated perfused rat kidney. Biochem J (1967) 2.41
Protocol for emergency EPR dosimetry in fingernails. Radiat Meas (2007) 2.41
EPR dosimetry in chemically treated fingernails. Radiat Meas (2007) 2.33
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia (1999) 2.24
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology (1995) 2.20
Ultra-fast three dimensional imaging of hyperpolarized 13C in vivo. MAGMA (2005) 2.17
Carbohydrate metabolism of the perfused rat liver. Biochem J (1967) 2.08
Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology (1992) 2.07
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer (2007) 2.00
District general managers: should they be medically qualified? Br J Hosp Med (1989) 1.93
Biogenesis of mitochondria: the mitochondrial gene (aap1) coding for mitochondrial ATPase subunit 8 in Saccharomyces cerevisiae. Nucleic Acids Res (1983) 1.89
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med (1999) 1.86
31P NMR studies of intracellular pH and phosphate metabolism during cell division cycle of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1981) 1.84
Sodium reabsorption in the perfused rat kidney. Am J Physiol (1973) 1.82
Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med (1994) 1.81
A standardized test for the identification and characterization of melanins using electron paramagnetic resonance (EPR) spectroscopy. Pigment Cell Res (1993) 1.80
Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer (1999) 1.79
Causes and effects of heterogeneous perfusion in tumors. Neoplasia (1999) 1.76
Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med (1999) 1.72
Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol (2003) 1.68
A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging (1998) 1.62
In vivo carbon-13 nuclear magnetic resonance studies of mammals. Science (1981) 1.61
Enzyme distribution along the nephron. Kidney Int (1984) 1.60
Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology (1993) 1.58
Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol (1993) 1.57
Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed (2002) 1.57
Electron paramagnetic resonance in human fingernails: the sponge model implication. Radiat Environ Biophys (2008) 1.55
pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol (1999) 1.48
Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology (1992) 1.47
An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR Biomed (1993) 1.45
Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicol Lett (2001) 1.44
Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed (2002) 1.44
In vivo dosimetry by electron spin resonance spectroscopy. Health Phys (1968) 1.43
Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy. Hum Gene Ther (1998) 1.43
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther (2000) 1.42
Correlation of minimum coronary lumen diameter with left ventricular functional impairment induced by atrial pacing. Am J Cardiol (1988) 1.39
Hyperparathyroid crisis and posterior mediastinal parathyroid adenoma: a case for preoperative localization. Surgery (1993) 1.38
Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol (1999) 1.38
Studies on human uterine cervix and rat uterus using S-, X- and Q-band electron-spin-resonance spectroscopy. Biochem J (1984) 1.38
Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study. Phys Med Biol (2007) 1.37
31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature (1982) 1.37
Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA (2004) 1.33
Development and evaluation of biocompatible films of polytetrafluoroethylene polymers holding lithium phthalocyanine crystals for their use in EPR oximetry. Biosens Bioelectron (2005) 1.30
Intracellular pH changes during the cell cycle in Tetrahymena. J Cell Physiol (1979) 1.30
The effects of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res (2001) 1.29
Simultaneous multi-site EPR spectroscopy in vivo. Magn Reson Med (1993) 1.28
In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer. Int J Radiat Oncol Biol Phys (1999) 1.27
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol (2003) 1.27
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed (1998) 1.27
Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1999) 1.26
Electronically tunable surface-coil-type resonator for L-band EPR spectroscopy. J Magn Reson (2000) 1.26
Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett (1992) 1.26
Radiation dose reconstruction from L-band in vivo EPR spectroscopy of intact teeth: Comparison of methods. Radiat Meas (2007) 1.25
Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat (2003) 1.24
Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. Free Radic Biol Med (1997) 1.23
Improved function with amino acids in the isolated perfused kidney. Am J Physiol (1982) 1.23
Critical oxygen tension in rat brain: a combined (31)P-NMR and EPR oximetry study. Am J Physiol Regul Integr Comp Physiol (2000) 1.22
Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med (1998) 1.22
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res (1996) 1.21
Simultaneous measurement of intracellular pH and Ca2+ using the fluorescence of SNARF-1 and fura-2. Am J Physiol (1991) 1.20
Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys (1998) 1.20
Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem Int (1990) 1.19
Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther (1998) 1.19
In vivo phosphorus-31 nuclear magnetic resonance reveals lowered ATP during heat shock of Tetrahymena. Science (1983) 1.18
Non-gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: A feasibility study. AJNR Am J Neuroradiol (2009) 1.17
Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys (1989) 1.16
EPR spectrometer for clinical applications. Magn Reson Med (2005) 1.16
pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol (1999) 1.16
Intraphagosomal oxygen in stimulated macrophages. J Cell Physiol (1995) 1.16
31P nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells. J Cell Biol (1982) 1.15
Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem (1996) 1.14
Hypoxia-sensitive NMR contrast agents. Magn Reson Med (1986) 1.14
Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med (1994) 1.13
Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res (1995) 1.13
Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia (2001) 1.13
Noninvasive measurement of the pH inside the gut by using pH-sensitive nitroxides. An in vivo EPR study. Magn Reson Med (1996) 1.13
Metabolic imaging of mild traumatic brain injury. Brain Imaging Behav (2012) 1.12
The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model. Gene Ther (2002) 1.12
High spatial resolution multi-site EPR oximetry. The use of convolution-based fitting method. J Magn Reson (2001) 1.12
Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Biomaterials (1996) 1.11